Revivify Gel: A Game-Changer in Mitigating Oxidative Stress in the Brain

A significant breakthrough has been made in combating oxidative stress-related neurodegenerative disorders using Revivify Gel.

TEMPLE, Texas – A collaborative team of leading researchers and physicians from Orion Institute for Translational Medicine, Emergent Biotechnologies LLC, Advance Pharmaceutical Inc., and Texas A&M University School of Medicine announced a significant breakthrough in combating oxidative stress-related neurodegenerative disorders using Revivify Gel. This groundbreaking study points to a promising new direction for mitigating the pathogenesis of diseases like Parkinson’s Disease (PD), Multiple Sclerosis (MS), and Alzheimer’s Disease (AD).

Revivify Gel, developed by Advance Pharmaceutical Inc., has been demonstrated to provide immediate relief from oxidative stress using multi-dimensional pathways. The latest study focuses on the potential for Revivify Gel to protect human brain microvascular endothelial cells (HBMEC) from oxidative damage and mitigate hypoxia-induced disruption of the blood-brain barrier.

“In vitro models show that Revivify Gel significantly reduces the permeability of the blood-brain barrier caused by hypoxia. This discovery has broad implications for addressing neurodegenerative disorders that arise from oxidative stress,” said Zubayeer Alam, a spokesperson for Revivify. “Our results point to the potential of Revivify Gel to improve motor activity, muscle stiffness, memory response, and overall body responses related to diseases like PD and AD.”

Read the full press release.